Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients
Public ClinicalTrials.gov record NCT00031473. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase III Study to Evaluate the Safety and Efficacy of Ribavirin Inhaled Solution in Preventing Progression of Upper Respiratory Tract Respiratory Syncytial Virus Infection to RSV Pneumonia in Blood and Bone Marrow Transplant (BMT) Recipient
Study identification
- NCT ID
- NCT00031473
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Interventions
- Virazole (Ribavirin) Inhalation Solution Drug
Drug
Eligibility (public fields only)
- Age range
- 5 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 1997
- Primary completion
- Not listed
- Completion
- Feb 28, 2003
- Last update posted
- Aug 26, 2010
1997 – 2003
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham (CASG) | Birmingham | Alabama | 35294 | — |
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| University of California, San Francisco | San Francisco | California | 94143 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| J. Whitcomb Riley Hosp for Chldrn - Indianapolis | Indianapolis | Indiana | 46202 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| St. Luke's Hospital (Kansas City, MO) | Kansas City | Missouri | 64134 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00031473, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 26, 2010 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00031473 live on ClinicalTrials.gov.